Introduction
============

Family studies support a genetic contribution to Behçet\'s disease (BD), with a sibling recurrence-risk ratio of 11-52. The class I MHC molecule, *HLA-B\*51* (*B\*51*), is the strongest known genetic risk factor for BD, however the gene immediately centromeric to *HLA-B*, *MICA*, has also been implicated in BD. Because of strong linkage disequilibrium (LD) between *HLA-B* and *MICA*, their respective contributions to BD susceptibility have been debated. A recent report has proposed that *B\*51* is not a BD susceptibility allele, and several studies have identified *B\*51-*independent association signals within the MHC.

Objectives
==========

To clarify the relationship between *B\*51* and BD, and to test for *B\*51*-independent genetic variation within the MHC that influences BD susceptibility.

Methods
=======

Using Illumina Human 370CNV SNP genotypes in a Turkish collection of 1244 BD patients and 1303 geographically-matched healthy subjects, we examined SNP haplotypes and LD patterns across the *HLA-B/MICA* region with Haploview. We performed SNP imputation of the MHC using IMPUTE2 and the 1000 Genomes Phase 1 dataset. We inferred classical HLA types and their amino acids using SNP2HLA. Association testing and regression analyses were performed using SNPTEST and SNP & Variation Suite 7.

Results
=======

We identified a *B\*51*(+) *HLA-B/MICA* haplotype that was strongly associated with BD (p=1.22E-46, OR 2.8). A *B\*51*(-) version of the same haplotype occurred at equal frequencies in cases and controls, demonstrating that *B\*51* is essential to the risk haplotype. Further, we found that rs2848713, a variant on the *MICA* end of the haplotype, conferred additional risk of BD in *B\*51*(+) individuals. Through imputation, we generated a set of 32,689 imputed SNPs. The 2 most strongly associated SNPs were 4.8Kb centromeric of *HLA-B* (p~min~=1.4E-50), but no SNP was more strongly associated with BD than was *B\*51* itself (p=1.3E-55). Conditioning on *B\*51* revealed an association near *HLA-A* (p~min~=5.4E-9), and upon adding a representative *HLA-A* SNP to the regression model, we detected residual association centromeric of *HLA-B* (p=1.5E-5). Analysis of imputed HLA types supported these findings. In addition to the association of BD with *B\*51* (p=2.2E-55), sequential regression of imputed HLA types identified associations of *HLA-A\*03* (p=1E-8), *HLA-C\*0701* (p=9.5E-4), and *HLA-B\*15* (p=1.2E-4) with BD. Stepwise forward regression of imputed *HLA-B* amino acids identified 6 *HLA-B* residues that together fully accounted for the regional association at *HLA-B.*

Conclusion
==========

This study affirms *B\*51* as the strongest risk factor of BD. We have provided strong evidence opposing a *B\*51*-independent role for *MICA* variants in BD susceptibility. We have identified significant effects of *HLA-A\*03* and *HLA-C\*0701*, which protect against BD, and *HLA-B\*15*, which confers risk of BD. We have identified a group of *HLA-B* amino acids, most of which reside in the antigen binding groove, that together account for the entire association signal at the *HLA-B* locus.
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